Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 27,900 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Celularity Inc | CELUW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.005 | -14.29% | 0.03 | 15:02:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0202 | 0.012 | 0.03 | 0.03 | 0.035 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 26 | 27,900 | 0.0166041 | 463 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 100 | 0.0124 | USD |
Celularity Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.47B | 144.52M | - | 17.98M | 14.19M | 0.10 | 103.87 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Celularity
| Date | Time | Source | Heading |
|---|---|---|---|
| 4/22/2024 | 07:00 | GlobeNewswire Inc. | Celularity Inc. to Host Investor and Analyst Research &.. |
| 4/19/2024 | 16:30 | GlobeNewswire Inc. | Celularity Inc. Announces Receipt of Nasdaq Notice Regarding.. |
| 4/18/2024 | 15:30 | GlobeNewswire Inc. | Celularity Abstract “Emerging Technologies for the.. |
| 4/15/2024 | 07:00 | GlobeNewswire Inc. | Celularity Announces Net Sales Trending Ahead of.. |
| 4/08/2024 | 08:00 | GlobeNewswire Inc. | Celularity to Present Data Showing Senescent Cell.. |
| 3/26/2024 | 08:00 | GlobeNewswire Inc. | Celularity Receives Healthcare Common Procedure Coding.. |
| 3/20/2024 | 08:15 | GlobeNewswire Inc. | Celularity Submits Request to U.S. FDA for Orphan Drug.. |
| 3/14/2024 | 08:15 | GlobeNewswire Inc. | Celularity CEO to Present on Cell Therapy’s Potential to.. |
| 3/12/2024 | 08:20 | GlobeNewswire Inc. | Celularity CEO to Present Keynote Address at 2024 Society.. |
| 3/07/2024 | 08:35 | GlobeNewswire Inc. | Celularity to Present Data Showing Cancer Tumor Reduction by.. |
| 2/23/2024 | 15:10 | GlobeNewswire Inc. | Celularity Announces 1-for-10 Reverse Stock Split |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
CELUW Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. |
